Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1Other hematologic neoplasm 1Gastrointestinal 1Breast 1

Conditions

Immune-related Adverse Event 1

Interventions

Early Intervention, Educational 26Interviews as Topic 23Educational Status 18Methods 17Practice Guidelines as Topic 15Standard of Care 14Specimen Handling 7Counseling 7Health Promotion 6Psychiatric Rehabilitation 5Proton Therapy 5Palliative Care 5Fluorodeoxyglucose F18 5Carboplatin 5Behavior Therapy 5Drug Therapy 4Cryotherapy 4Telemedicine 3Restraint, Physical 3Radiotherapy 3Patient Navigation 3Paclitaxel 3Nutrition Assessment 3Mindfulness-Based Stress Reduction 3Mindfulness 3Melphalan 3Exercise Test 3Blood Specimen Collection 3Acupressure 3pazopanib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Antineoplastic Agents × Other solid neoplasm × Clear all
NCT06702566 2024-11-25

The Effect of Serum Ferritin in irAE

Tianjin Medical University Cancer Institute and Hospital

Phase NA Recruiting
1,500 enrolled
Other hematologic neoplasmOther solid neoplasm

Immune-related Adverse Event

Data powered by HemOnc (CC BY 4.0) Colophon âš¡